Insulinotropic hormone GLP-1 (7-36) and uses thereof
   
   

Derivatives of glucagon-like peptide I (GLP-1) and especially GLP-1(7-36) have been found to have insulinotropic activity. The invention pertains to the use of GLP-1(7-36) for the treatment of type II diabetes mellitus.

Los derivados glucagon-como del peptide I (GLP-1) y especialmente GLP-1(7-36) se han encontrado para tener actividad insulinotropic. La invención pertenece al uso de GLP-1(7-36) para el tratamiento del tipo mellitus de la diabetes de II.
 
Web www.patentalert.com

< Glucagon-like insulinotropic peptide analogs, compositions, and methods of use

< Method of producing clonal cell strains which express exogenous DNA encoding glucagon-like peptide 1

> Cloned glucagon-like peptide 2 receptors

> DNA encoding insulinotropic hormone
~ 00125